• Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Careers
  • Tools
Finnegan
Yoonhee Kim
Yoonhee Kim
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4214
yoonhee.kim@finnegan.com yoonhee.kim@finnegan.com

Yoonhee Kim

Associate

  • +1 202 408 4214 +1 202 408 4214
  • yoonhee.kim@finnegan.com yoonhee.kim@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard
Yoonhee Kim
Yoonhee Kim focuses on complex patent litigation before U.S. district courts and the U.S. Court of Appeals for the Federal Circuit and on patent prosecution in the chemical and pharmaceutical fields, including Hatch-Waxman litigation arising from the filing of Abbreviated New Drug Applications (ANDA).

Yoonhee's experience includes developing pre-litigation strategy, fact discovery, preparing witnesses, developing validity and infringement strategies, motion practice, taking and defending depositions, and handling day-to-day litigation activities. He also has experience handling contested proceedings before the Patent Trial and Appeal Board (PTAB), including interferences and inter partes reviews (IPRs).

In addition to his litigation practice, Yoonhee frequently advises clients on various contracts, including collaboration agreements, nondisclosure agreements, and other types of IP transactions. Yoonhee's practice also includes preparing validity, infringement, and freedom-to-operate opinions and conducting due diligence investigations and portfolio reviews for clients in the petrochemical and pharmaceutical fields. He maintains an active patent prosecution practice, preparing and prosecuting U.S. patent applications and coordinating global patent portfolio management in the chemical and pharmaceutical arts.

Yoonhee gained significant patent experience while working as a Korean patent attorney in Seoul, where he handled a wide range of matters including trials, prosecution, and infringement and validity opinions.

Et Cetera

  • Recipient of the Edward C. Bou Award for the American University Washington College of Law Class of 2014.
  • Served as a legal intern to Director and Chief IP Counsel in the Office of Policy Planning at the U.S. Federal Trade Commission, 2013.
  • Served as a research assistant to Professor Jorge L. Contreras on the issues at the intersection of IP and antitrust law, including standard essential patents and Fair, Reasonable, and Non-Discriminatory (FRAND) licensing terms, 2013-2014. 

Experience

Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.

Secured a permanent injunction against generic defendant on behalf of Valeant in Hatch-Waxman patent infringement litigation concerning an ANDA for generic versions of Carac®.

2:16-cv-04344, D.N.J., Judges Linares, Dickson

Insights

Federal Circuit IP Blog

Federal Circuit Confirms Joint Inventorship on Nobel Prize Winner’s Cancer Treatment Patents Federal Circuit Confirms Joint Inventorship on Nobel Prize Winner’s Cancer Treatment Patents

July 21, 2020

Federal Circuit IP Blog

Corroborating Evidence of Conception Must Be Independent of Inventor Testimony Corroborating Evidence of Conception Must Be Independent of Inventor Testimony

May 4, 2018

Federal Circuit IP Blog

USPTO Can Receive Its Attorneys’ Fees for Applicant Appeals to District Court USPTO Can Receive Its Attorneys’ Fees for Applicant Appeals to District Court

June 30, 2017

Federal Circuit IP Blog

No Abuse of Discretion in Awarding Prejudgment Interest Based in Part on Patents Not Yet Issued at the Time of Hypothetical Negotiation No Abuse of Discretion in Awarding Prejudgment Interest Based in Part on Patents Not Yet Issued at the Time of Hypothetical Negotiation

April 18, 2017

IP FDA Blog

FDA Final Rule on Citizen Petitions, Petitions for Stay of Action, and Submission of Documents to Dockets FDA Final Rule on Citizen Petitions, Petitions for Stay of Action, and Submission of Documents to Dockets

January 10, 2017

IP FDA Blog

CAFC Holds Patentee’s Diligence Required for Antedating Prior Art Is Reasonably Continuous in Perfect Surgical v. Olympus CAFC Holds Patentee’s Diligence Required for Antedating Prior Art Is Reasonably Continuous in Perfect Surgical v. Olympus

December 1, 2016

3 more

Professional Activities

  • Virginia State Bar
  • Korean Patent Attorney Association
  • Order of the Coif
Admissions and Education

Admissions

  • District of Columbia
  • Virginia
  • Korean Intellectual Property Office

Education

American University, Washington College of Law
J.D., magna cum laude, 2014
Seoul National University
B.S., Chemical Engineering, 2005

Languages

  • Japanese
  • Korean

Yoonhee's Practices

Patent Litigation
Branded Hatch-Waxman (ANDA)
Patent Trial
Pre-Trial Strategy
Patent Office Examinations
Prosecution
Reexaminations
Patent Portfolio Management, Monetization, and Transactions
Opinions and Counseling
Post-Grant Proceedings
Interferences
IPR, PGR, and CBM

Yoonhee's Industries

Energy
Chemical
Life Sciences
Pharmaceutical

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

  • Privacy
  • Disclaimer
  • EEO Statement

© 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP